It’s been said that “competition makes us faster, but collaboration makes us better!” And while the author of this quote may still be unknown, the message that it inspires is intensely familiar. The M Lab™ Collaboration Centers from MilliporeSigma are fundamental to the development of innovative resolutions to common bioproduction problems. The technical expertise of the M Lab™ Collaboration Centers spans all aspects of the bioprocessing spectrum, and the facilities are located in key biopharma hubs around the world—with experts able to tackle region-specific challenges, as well as the toughest scientific problems. In the podcasts below, you can listen to compelling stories of novel solutions and innovative application of technologies that brought M Lab™ Collaboration Centers team members together with various biopharmacuetical manufacturers to make science, better.

Podcast Series: Collaborations in Bioprocessing

Virtual Reality Conference

Digital Tools Push Single-Use Technology Challenges to the Side

In a previous podcast, we heard about the power of virtual collaborations during a pharmaceutical company’s push to meet their manufacturing goals during a global pandemic with much of the world on hold or scrambling to find solutions to fit their needs. Unfortunately, the...
Abstract network

Virtual Collaborations Push Pharma Forward During Pandemic

With regions of the world cycling through societal re-openings and shutdowns due to the ongoing coronavirus pandemic, pharma and life science companies are tasked with trying to find creative solutions that help keep production lines moving, as well as drive innovation forward. For instance,...
Scientist Interacting With The Computer Via Touch Screen

Trends in Bioprocess 4.0 and their Impact on Biomanufacturing

The biomanufacturing industry is currently undergoing a revolution in how it produces biopharmaceutical products. The driving force behind this paradigm shift is known as Bioprocess 4.0 or Industry 4.0. The approach focuses on how to apply data, predictive modeling, analytics, machine learning, artificial intelligence,...
ImmunoglobulinG Antibody Molecule

Helping Biosimilars Emerge into Global Markets Takes a Practiced Hand

Currently, almost 60 percent of drugs in development are being created by emerging biotech companies focused on therapies for niche diseases with small patient populations. For emerging biotech and small companies in early-stage clinical development, accessing the market as quickly as possible is immensely...

Find the Right Fit when Tackling Late Stage Bioprocessing Challenges

In this GENcast, we explore different troubleshooting techniques that the M Lab™ Collaboration Center experts employed, together with Biogen, to solve their facility fit challenges.

Antibody Drug Conjugates: Manufacturing Precision Guided Therapeutics

In this GENcast, we hear from a panel of ADC experts about how they have addressed some of the most challenging aspects of manufacturing these complex therapeutics and how they are reading the current ADC manufacturing terrain.

Vaccinating the World One Collaboration at a Time

The experts from the M Lab™ Collaboration Centers at MilliporeSigma are no strangers to knowledge sharing and have been involved in supporting a number of successful vaccine development projects. In this GENcast, we talk to a diverse group of public health scientists and discuss their vaccine development projects and how the M Lab Collaboration Centers were able to assist them toward positive outcomes.

GENcast: Explore, Learn, and Collaborate on Bioprocessing Challenges in China

We connected recently with a few members of the M Lab Collaboration Centers to discuss some of the recent, successful projects they collaborated on with clients in China. They discuss some of the challenges they faced on their project, how they set out to resolve those issues, and what the future holds for them and the Chinese biopharma market.

GENcast: Explore, Learn, and Collaborate as Next-Generation Bioprocessing Moves Toward Future Horizons

In this new sponsored podcast, our two panelists discuss the recent completion of a Horizon2020 collaborative project that brought together Lek Pharmaceuticals and the M Lab Collaboration Centers and led to the implementation of a fully integrated manufacturing platform for mAbs based on continuous chromatography, in addition to a range of other downstream bioproduction innovations.

GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing

In this podcast, we will hear from several members of the M Lab Collaboration Centers’ viral safety team who will discuss the common viral safety challenges that drug manufacturers encounter and the innovative solutions they have developed to address these issues.
Scroll Up